|
Identification and pre-clinical development of novel integrin modulators
Project funded by own resources |
Project title |
Identification and pre-clinical development of novel integrin modulators |
Principal Investigator(s) |
Krähenbühl, Stephan Gygax, Daniel
|
Organisation / Research unit |
Bereich Medizinische Fächer (Klinik) / Klinische Pharmakologie (Krähenbühl), Departement Pharmazeutische Wissenschaften / Pharmakologie (Krähenbühl) |
Project start |
01.01.2013 |
Probable end |
31.12.2015 |
Status |
Completed |
Abstract |
Inhibitors of the Lymphocyte function-associated antigen 1 (LFA1) have been shown to modulate lymphocyte function and to act as immunosppressants. The aim of the study is to design novel modulators of LFA1 and to characterize these substances pharmacologically and toxicologically in vitro and in vivo in experimental animals.
KTI Project Nr. 15265.1 PFLS-LS |
Financed by |
Other funds
|
|
|
|
MCSS v5.8 PRO. 0.676 sec, queries - 0.000 sec
©Universität Basel | Impressum
| |
29/03/2024
Research Database / FORSCHUNGSDATENBANK
|